Mark C. Capone
2018
In 2018, Mark C. Capone earned a total compensation of $7.1M as President and Chief Executive Officer at Myriad Genetics, a 35% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $817,920 |
|---|---|
| Salary | $852,000 |
| Stock Awards | $5,374,050 |
| Other | $10,980 |
| Total | $7,054,950 |
Capone received $5.4M in stock awards, accounting for 76% of the total pay in 2018.
Capone also received $817.9K in non-equity incentive plan, $852K in salary and $11K in other compensation.
Rankings
In 2018, Mark C. Capone's compensation ranked 1,221st out of 14,244 executives tracked by ExecPay. In other words, Capone earned more than 91.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,221 out of 14,244 | 91st |
Division Manufacturing | 418 out of 5,758 | 93rd |
Major group Chemicals And Allied Products | 128 out of 2,119 | 94th |
Industry group Drugs | 100 out of 1,808 | 95th |
Industry In Vitro and In Vivo Diagnostic Substances | 2 out of 72 | 97th |
Source: SEC filing on October 10, 2018.
Capone's colleagues
We found four more compensation records of executives who worked with Mark C. Capone at Myriad Genetics in 2018.